News
Risks to BMY include potential for tariffs to raise costs of drugs manufactured outside of the U.S. Moreover, drug pricing ...
Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find ...
Business Insider's July 30 virtual event features executives talking about procurement innovation strategies. The panel ...
18h
MedPage Today on MSNBiomarkers Promising to Predict Biologic Drug Response in Crohn’sWhile analysis of 18 identified biomarkers for adalimumab (Humira) initially yielded an AUC of 0.86 (95% CI 0.58-0.97), the ...
9h
Zacks.com on MSNInvestors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to KnowZacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol ...
For those looking for a quick hit, speculators may consider the 47.50/48 bull call spread expiring July 18. This transaction ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results